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We identified the synthetic cannabinoid JWH-203 [1-pentyl-3-(2'-
chlorophenylacetyl) indole] by coordination of various
spectroscopic analytical procedures; the data that we obtained
may be useful for confirming the presence of this
phenylacetylindole in illegally distributed products. In previous
studies, several molecules that were identified as synthetic
cannabinoids were found in different products advertised as herbal
mixtures; the identification of new psychotropic molecules
surreptitiously included in products allows them to be added to the
official list of psychotropic substances possessing cannabimimetic
activity. We used liquid chromatography–mass spectrometry and
gas chromatography–mass spectrometry techniques to determine
basic information about the structure of JWH-203; our data were
corroborated by the results of liquid chromatography–ultraviolet
spectroscopy and confirmed by nuclear magnetic resonance
analysis and high-resolution accurate mass detection.
Introduction
Various psychotropic substances are being sold, transported,
and distributed worldwide, both legally and illegally. Various
papers refer on the structure-activity relationship for some
cannabimimetic substances at the cannabinoid CB1 and CB2 re-
ceptors (1–4) and more recently, various synthetic cannabi-
noids were identified as psychoactive adulterants in herbal
products (5–10). Analytical data that would be useful for iden-
tifying these compounds are not readily available in the liter-
ature, although several authors have published the analytical
details of single or limited numbers of molecules with
cannabimimetic structures that were isolated from herbal
products (11–21). In effect, not all data necessary to identify the
structures of all cannabimimetic substances by instrumental
analysis are currently available. Moreover, it is only possible to
include substances on a country’s official list of psychotropic
substances after the presence of individual synthetic cannabi-
noids have been identified in products distributed within that
country. The publication of analytical details produced by var-
ious spectroscopic methods is an important means by which to
fight the adulteration of herbal products.
In collaboration with Carabinieri Headquarters for Health-
care NAS (Anti Fraud Squad of Milan), Carabinieri Military
Police (IT)—Ministry of Health, our analytical research labo-
ratories were able to identify some synthetic cannabinoids in
various herbal products. Recently, following an official mission
of N.A.S. dated November 15, 2010, we identified the molecule
JWH-203 in a sample withdrawn from a 2.3-kg sized powder
imported from China and declared as a “chemical”. The infor-
mation about JWH 203 was disseminated via the “Early
Warning System” of the European Monitoring Centre of Drugs
and Drug Abuse (EMCDDA) on Septempber 29, 2010, after the
Latvian Institute of Organic Synthesis identified 1.8 kg seized
powder coming from China as JWH-203 (22). Actually only the
EI-MS and ATR-IR spectra of JWH-203 result to be available in
Toxichem Krimtech (23).
As the source of the analytical approach, we have adapted the
methods of Auwärter et al. (13) and Uchiyama et al. (14).
A combination of spectroscopic methods was used. JWH-
203 has a chlorophenylacetyl group in place of the naphthoyl
ring present in most aminoalkylindole cannabinoid compounds
which were identified in “herbal” products so far. The structure
differs from JWH-250 and JWH-251 (20,21), which have a
methoxy and a methyl substituent, respectively, in the 2' posi-
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Abstract
Short Communication
Figure 1. Structure of the cannabinomimetic compound 1-pentyl-3-(2'-
chlorophenylacetyl) indole (JWH-203).
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tion. The pharmacological cannabimimetic activity of JWH-203
is described by Huffman (4). Concerning the affinities for the
cannabinoid CB1 and CB2 receptors, Huffman et al. (3) affirms
that 3-(2-substituted phenylacetyl) indoles have good to high
affinity for the CB1 receptor and that JWH-203 is one showing
the highest affinity. The work presented herein describes the
methods that we used to identify and then confirm the struc-
ture of JWH-203, also known as 1-pentyl-3-(2'-chlorophenyl-
acetyl) indole, as reported in Figure 1.
Experimental
Chemicals and reagents
HPLC-grade formic acid, methanol, and water were pur-
chased from VWR International (Milan, Italy). Pall GH Polypro
filters (hydrophilic polypropylene membrane) with 0.45-µm
pore size were also purchased from VWR International.
Sample preparation and extraction
The sample delivered from the Anti Fraud Squad of Milan de-
rived from a greater quantity of a substance declared as “chem-
ical” and imported from China. The analytical question was the
qualitative identification of the presumed synthetic cannabi-
noid substance.
A 250-mg aliquot of the sample was placed in a 10-mL glass
vial, and 10 mL of methanol was added. This was sonicated for
10 min, then left to settle for 10 min, and then filtered through
a GH Polypro 0.45-µm filter (first solution). The extract was di-
luted 1:20 with methanol.
Instrumental analysis
The sample solution was qualitatively analyzed by liquid
chromatography–mass spectrometry (LC–MS–MS) with posi-
tive electrospray ionization (ESI+). The instrument was a Shi-
madzu integrated HPLC system (Shimadzu Italia), which con-
sisted of a Shimadzu CBM 20 A system controller, two
Shimadzu LC 20 AD XR pumps (including a Shimadzu de-
gasser DGU A3), a Shimadzu SIL 20 ACXR autosampler, and a
Shimadzu CTO 20 AC column oven. The analytes were de-
tected using an Applied Biosystems 2000 MS with Analyst soft-
ware (Version 1.4.1) equipped with a TurboIonSpray Source. A
stainless steel column (Supelcosil) (150 mm × 3 mm) with a
120-Å pore diameter (3-µm particle size) was used. The analysis
was carried out with a binary mobile phase consisting of sol-
vent A (0.1% formic acid in water) and solvent B (0.1% formic
acid in methanol). The elution program was 40% B (5 min
hold) to 60% B (5–15 min), then 60% B with 5 min hold (15–
20 min), then 80% B (20–35 min), followed by 98% B (35–50
min) at a flow rate of 0.3 mL/min.
The LC–MS–MS-ESI+ conditions for multiple reaction mon-
itoring (MRM) were established using the first solution (see
Sample preparation and extraction section). This solution was
injected by continuous infusion at 10 µL/min in +Q1 mode and
+MS2 mode. The following conditions were adopted: declus-
tering potential (DP; 34 V), focusing potential (FP; 343 V), en-
trance potential (EP; 11 V), cell entrance potential (CEP; 15 V),
collision energy (CE; 40 V), and cell exit potential (CXP; 34 V).
The mass spectrum of JWH-203 contains the protonated
molecule [M+H]+ at m/z 340; this ion produces abundant
daughter ions at m/z 125 and m/z 214.
The same chromatographic conditions (without formic acid
in A and B phases) were adopted in the LC–PDA analysis to pro-
duce the UV spectrum. LC was performed with an HPLC Shi-
madzu system consisting of a system controller SCL–10 A vp;
two LC-10AD VP pumps; a Rheodyne injection valve (7725i, 20-
µL loop); a diode-array detector (DAD) SPD-M10A VP; and
Shimadzu Class-VP-5 acquisition software. Separation was
achieved on a CHROMPACK C18 110 A column (250 × 4.6 mm,
5 mm) from Phenomenex (Milan, Italy) using the sample so-
lution diluted as described in the Sample preparation and ex-
traction section. The wavelength of the PDA detector was set
from 190 to 400 nm.
GC–MS analyses were carried out with a Shimadzu 2010
GC coupled to a Shimadzu 2010 MSD quadrupole MS (Shi-
madzu, Italia). Helium was used as the carrier gas at a flow rate
of 1 mL/min. Suitable identification of the analyte was achieved
using an Equity-5, a poly (5% diphenyl, 95% dimethylsiloxane)
stationary phase column with 30 m × 0.25-mm internal di-
ameter and 0.25-µm film thickness (Supelco, Milan, Italy).
The oven temperature program was initially 80°C (held for
1 min.) and then increased to 300°C at a rate of 5°C/min (held
for 10 min). The injector temperature was 240°C, and the
splitless injection mode (1 min) was used. The ion source and
the transfer line temperatures were 200°C and 320°C, respec-
tively. The MS instrument was operated in positive electron
ionization mode (EI+) with automatic gain control, with 70 eV
of electron energy and 250 mA of emission current. The MS
was operated in the full scan mode from m/z 40 to 400. An
aliquot (1 µL) of the sample solution, diluted as described in
the Sample preparation and extraction section, was injected for
the GC–MS analysis.
The nuclear magnetic resonance (NMR) spectrometer
AV-600 MHz Bruker was operated at a proton frequency of
600.13 MHz and a carbon frequency of 151.91 MHz; it was
equipped with a 5-mm TXI Z-GRAD probe. The 1H and 13C
NMR spectra were recorded at 25°C. DMSO-d6 was the op-
timal solvent. By performing a set of mono- and two-dimen-
sional experiments, we were able to establish the complete as-
signment of the following signals: 1H NMR, correlation
spectroscopy (COSY), total correlation spectroscopy (TOCSY),
heteronuclear multiple bond coherence (HMBC), and het-
eronuclear multiple quantum coherence (HMQC).
To evaluate the accurate mass, the sample was analyzed on
an Agilent 1200SL, 6210 TOF-ESI(+). For this system, a Hy-
persil GOLD column (100 × 2.1 mm, 3-μm particle size,
Thermo Scientific, Bellefonte, PA) was used; it was operated in
gradient mode. The mobile phases were as follows: solvent A
(0.1% formic acid in water) and solvent B (0.1% formic acid in
acetonitrile). The elution program was 50% B (5 min hold) to
100% B (5–8 min), then 100% B (8–20 min) at a flow rate of
0.4 mL/min. Dry gas (N2) was set at 10 L/min and interface
temperature at 350°C, fragmentor at 120 V, and skimmer at
60 V. The MS data were recorded with a range of m/z 100–1200
in the scan mode.
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Results and Discussion
The unknown chemical, detected as a
peak at 10.6 min in the HPLC–DAD trace
of the test solution, was characterized by
LC–UV spectroscopy (maxima at 198.3,
244.2, and 305.8 nm) (Figure 2). This UV
spectrum shows some similarities to the
spectra of other synthetic cannabinoids.
The LC–MS–MS spectrum in Figure 2
has a major signal at m/z 340 [M+H]+. In
the accurate mass spectrum, the major
ion peak showed a protonated molecular
ion signal at m/z 340.1471 in the positive
mode, and the molecular weight was
compatible with the molecular formula
C21H22NOCl. The LC–MS–MS spectrum
shown in Figure 2 provided evidence that
a m/z 125 ion was very abundant, and
the GC–MS spectrum in Figure 3 re-
vealed a very abundant m/z 214 ion. Con-
sidering that two other ions, m/z 144 and
m/z 116, are present in the same GC–MS
spectrum characteristic of the known
structure of the m/z 214 ion in similar
synthetic cannabinoids (e.g., JWH-018
and JWH-250) (17,20,21), it is evident
that the m/z 125 ion completes the struc-
ture of the synthetic cannabinoid with a
molecular weight of m/z 339. The struc-
ture of the m/z 125 ion, which contains
Cl as substitute in a benzylic ring, was
confirmed by an isotopic ion at m/z 341,
as revealed in the GC–MS spectrum,
where the ion [M]+ 339 represents the
molecular ion.
The 1H NMR and 2D COSY and TOCSY
experiments permitted us to assign spin
systems to indole and bisubstituted
benzyl structures. The absence of a symmetric system AA' BB',
typical of para substitution, was evident and allowed us to ex-
clude this isomer. The presence of clear symmetry in the region
between 7.5 and 7.2 ppm (DMSO) permitted us to exclude the
meta substitution. The long-range heteronuclear chemical
shift correlation (HETCOR) (C–H) coupling revealed the fol-
lowing useful data that allowed us to identify the ortho sub-
stitution with certainty: the benzylic CH2 showed one three-
bond coupling with a quaternary C and one three-bond
coupling with only an aromatic CH at 132.8 ppm (Figure 4).
This C–H coupling would occur only with ortho substitution,
because in the case of meta substitution, the benzylic CH2
would have connections with two CH aromatics. Our results
can be simplified in Figure 5.
The accurate mass measurement revealed [M+H]+ at
340.1471; this measurement is compatible with the molec-
ular structure of 1-pentyl-3-(2'-chlorophenylacetyl) indole
(JWH-203).
Figure 3. GC–MS mass spectrum of the intense peak appearing at retention time 44.5 min (JWH-203) and
principal ion attributions.
Figure 2. Data from HPLC–DAD (UV spectrum at λ = 305.8 nm) and LC–MS–MS-ESI+ for the intense peak
appearing at retention time 10.6 min (JWH-203).
Figure 4. NMR HETCOR long-range C–H coupling, which identifies the
ortho Cl substitution.
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Conclusions
Our research focused on applying methods to identify new
cannabinoids as they appear in the market, and to provide
simple analytical information that will be useful for molecular
identification. In the present paper, we identified a substance
that has not yet been found by us in herbal mixtures, but was
imported to Italy as a raw material around November 2010.
Our analytical data confirmed the identity of JWH-203 [1-
pentyl-3-(2'-chlorophenylacetyl) indole], and our method per-
mitted us to rapidly identify this synthetic cannabinoid and in-
clude it in a database containing JWH compounds that have
been identified in the illegal market.
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Figure 5. Chemical structure corresponding to the long-range HETCOR
(C–H) coupling data: the benzylic CH2 coupling with a quaternary C and
with an aromatic CH.
